Literature DB >> 24573716

Racial disparities in the proportion of current, unresolved hepatitis C virus infections in the United States, 2003-2010.

Gui Liu1, Scott D Holmberg, Saleem Kamili, Fujie Xu.   

Abstract

BACKGROUND: The hepatitis C virus (HCV) antibody test alone does not distinguish current from resolved infections. AIM: The study aimed to describe the percentage of current HCV infection, defined by HCV RNA positivity, among those tested positive for anti-HCV, and to examine characteristics of those with current infection.
METHODS: Using nationally representative data from the 2003 to 2010 National Health and Nutrition Examination Surveys, descriptive analyses and regressions were performed on data from anti-HCV-positive adults aged ≥ 40 years.
RESULTS: Of 13,909 participants examined, 304 were anti-HCV-positive. Of these, 238 or 75.3% [95% confidence interval (CI) 67.5-81.8%] had detectable viral RNA. The percentage of current, unresolved HCV infection was highest among non-Hispanic Blacks (91.1%) and lowest among those with a college education (57.3%). In multivariate analyses, non-Hispanic Blacks were more likely to have current HCV infection compared to non-Hispanic Whites (adjusted odds ratio 3.9, 95% CI 1.6-9.2). Among persons with current HCV infection, most had elevated alanine aminotransferase (56.5%) or aspartate aminotransferase (71.8%) levels, but only 35.3% reported having been diagnosed with any abnormal liver conditions. Excessive alcohol drinking was reported by 27.3% of participants with current HCV infection.
CONCLUSIONS: Among adults aged ≥ 40 years who had ever been infected with HCV, approximately three-quarters had current, unresolved HCV infection. Non-Hispanic Blacks were more likely to have current infection than non-Hispanic Whites. The majority of those with current infection had abnormal liver function tests but had not received appropriate diagnoses. Many currently infected persons would benefit from lifestyle modifications to avoid the multiplicative effect of alcohol on HCV infection.

Entities:  

Mesh:

Year:  2014        PMID: 24573716     DOI: 10.1007/s10620-014-3059-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.

Authors:  Alexander J Thompson; Andrew J Muir; Mark S Sulkowski; Dongliang Ge; Jacques Fellay; Kevin V Shianna; Thomas Urban; Nezam H Afdhal; Ira M Jacobson; Rafael Esteban; Fred Poordad; Eric J Lawitz; Jonathan McCone; Mitchell L Shiffman; Greg W Galler; William M Lee; Robert Reindollar; John W King; Paul Y Kwo; Reem H Ghalib; Bradley Freilich; Lisa M Nyberg; Stefan Zeuzem; Thierry Poynard; David M Vock; Karen S Pieper; Keyur Patel; Hans L Tillmann; Stephanie Noviello; Kenneth Koury; Lisa D Pedicone; Clifford A Brass; Janice K Albrecht; David B Goldstein; John G McHutchison
Journal:  Gastroenterology       Date:  2010-04-24       Impact factor: 22.682

Review 2.  Hepatitis C virus infection in USA: an estimate of true prevalence.

Authors:  Eric Chak; Andrew H Talal; Kenneth E Sherman; Eugene R Schiff; Sammy Saab
Journal:  Liver Int       Date:  2011-03-16       Impact factor: 5.828

Review 3.  Current status of treatment for chronic hepatitis C virus infection.

Authors:  R Talwani; B L Gilliam; S A Rizza; V Nehra; Z Temesgen
Journal:  Drugs Today (Barc)       Date:  2012-03       Impact factor: 2.245

4.  Interaction of alcohol intake and cofactors on the risk of cirrhosis.

Authors:  Tommaso Stroffolini; Gaetano Cotticelli; Emanuela Medda; Marco Niosi; Camillo Del Vecchio-Blanco; Giovanni Addolorato; Enzo Petrelli; Maria T Salerno; Antonio Picardi; Mauro Bernardi; Piero Almasio; Stefano Bellentani; Lorenzo A Surace; Carmela Loguercio
Journal:  Liver Int       Date:  2010-05-14       Impact factor: 5.828

5.  Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis.

Authors:  G Corrao; S Aricò
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

Review 6.  Chronic hepatitis C treatment patterns in African American patients: an update.

Authors:  Samuel Daniel
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

7.  Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.

Authors:  Moutaz Derbala; Nasser Rizk; Fatima Shebl; Saad Alkaabi; Nazeeh Eldweik; Anil John; Manik Sharma; Rafie Yaqoob; Muneera Almohanadi; Mohammed Butt; Khaled Alejji
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

8.  Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.

Authors:  Monika Sarkar; Peter Bacchetti; Phyllis Tien; Elizabeth Mileti; Audrey L French; Brian R Edlin; Marla Keller; Eric Seaberg; Marek J Nowicki; Mary Young; Marion G Peters
Journal:  Dig Dis Sci       Date:  2012-11-24       Impact factor: 3.199

9.  Testing for HCV infection: an update of guidance for clinicians and laboratorians.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-05-10       Impact factor: 17.586

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  7 in total

1.  Hospital-Based Hepatitis C Screening of Baby Boomers in a Majority Hispanic South Texas Cohort: Successes and Barriers to Implementation.

Authors:  Barbara S Taylor; Joshua T Hanson; Poornachand Veerapaneni; Roberto Villarreal; Kristin Fiebelkorn; Barbara J Turner
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

2.  Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Authors:  Eleanor E Friedman; Hazel D Dean; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-06       Impact factor: 2.792

3.  People and places: Relocating to neighborhoods with better economic and social conditions is associated with less risky drug/alcohol network characteristics among African American adults in Atlanta, GA.

Authors:  Sabriya L Linton; Hannah L F Cooper; Ruiyan Luo; Conny Karnes; Kristen Renneker; Danielle F Haley; Josalin Hunter-Jones; Zev Ross; Loida Bonney; Richard Rothenberg
Journal:  Drug Alcohol Depend       Date:  2015-12-10       Impact factor: 4.492

4.  Hepatitis C Virus Screening: Factors Associated With Test Completion in a Large Academic Health Care System.

Authors:  Monica L Kasting; Shannon M Christy; Richard R Reich; Julie A Rathwell; Richard G Roetzheim; Susan T Vadaparampil; Anna R Giuliano
Journal:  Public Health Rep       Date:  2021-10-25       Impact factor: 3.117

5.  Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013-2015.

Authors:  Monica L Kasting; Anna R Giuliano; Richard R Reich; Richard G Roetzheim; David R Nelson; Elizabeth Shenkman; Susan T Vadaparampil
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-27       Impact factor: 4.254

6.  "Test, Listen, Cure" (TLC) Hepatitis C Community Awareness Campaign.

Authors:  Steven S Coughlin
Journal:  JMIR Res Protoc       Date:  2015-02-06

7.  Black-white racial disparities in sepsis: a prospective analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

Authors:  Justin Xavier Moore; John P Donnelly; Russell Griffin; Monika M Safford; George Howard; John Baddley; Henry E Wang
Journal:  Crit Care       Date:  2015-07-10       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.